Do patients with ST segment elevation myocardial infarction in Killip class i need intensive cardiac care after a successful primary percutaneous intervention?

Acute Cardiac Care

Volumn 11, Issue 4, 2009, Pages 243-246

  Viana Tejedor, Ana ^a   López De Ś, Esteban ^a   Peña Conde, Laura ^a   Salinas Sanguino, Pablo ^a   Dobarro, David ^a   Rey Blas, Juan Ramón ^a   Armada Romero, Eduardo ^a   López Sendón, José ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Coronary care unit; Killip I; STEMI

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INOTROPIC AGENT; LOW MOLECULAR WEIGHT HEPARIN; NITRATE;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CAUSE OF DEATH; CORONARY CARE UNIT; CORONARY STENT; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; HEART FAILURE; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HYPOTENSION; IMPLANTATION; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; ST SEGMENT ELEVATION; STROKE; SURVIVAL RATE; SURVIVAL TIME;

AFTERCARE; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAUSE OF DEATH; CORONARY CARE UNITS; DISEASE-FREE SURVIVAL; ELECTROCARDIOGRAPHY; FEMALE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INTENSIVE CARE; KAPLAN-MEIERS ESTIMATE; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT READMISSION; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SPAIN; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 72049129683     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.1080/17482940903362588     Document Type: Article

References (16)

1. Antman E, Hand M, Armstrong P, Bates E, Green L, Halasyamani L, et al. 2007 Focused update of the ACC/ AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol. 2008;51:210-247
2. Grines CL, Marsalese DL, Brodie B, Griffin J, Donohue B, Costantini CR, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. J Am Coll Cardiol. 1998; 31:967-972
3. Hasin Y, Danchin N, Filippatos GS, Heras M, Janssens U, Leor J, et al. Recommendations for the structure, organization, and operation of intensive cardiac care units. Eur Heart J. 2005;26:1676-1682
4. Killip T III, Kimball JT. Treatment of myocardial infarction in a coronary care unit: A two-year experience with 250 patients. Am J Cardiol. 1967;20:457-464
5. Grines CL, Browne KF, Marco J, Rothbaum D, Stone GW, O'Keefe J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328:673-679 (Pubitemid 23073368)
6. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopenspirger MR, Gersh BJ. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med. 1993;328:685-691
7. Zijlstra F, Jan de Boer M, Moorntje JCA, Reiffer S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993;328:680-684
8. Michels KB, Yusif S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation. 1995;91:476-485
9. Weaver WD, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction. JAMA. 1997;278:2093-2098 (Pubitemid 28016233)
10. Topol EJ, Burek K, O'Neill WW, Kewman DG, Kander NH, Shea MJ, et al. A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion. N Engl J Med. 1988;318:1083-1088
11. Newby LK, Califf RM, Guerci A,Weaver WD, Col J, Horgan JH, et al. Early discharge in the thrombolytic era: An analysis of criteria for uncomplicated infarction from the global utilization of streptokinase and t-PA for occluded coronary arteries (GUSTO) trial. J Am Coll Cardiol. 1996;27:625-632
12. Ellis SG, Topol EJ, George BS, Kereiakes DJ, Debowey D, Sigmon KN, et al. Recurrent ischemia without warning: analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation. 1989;80:1159-1165
13. Volpi A, de Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, et al. Predictors of nonfatal reinfarction in survivors of myocardial infarction after thrombolysis. J Am Coll Cardiol. 1994;24:608-615
14. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe J, et al. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: A comparison of thrombolytic therapy and primary angioplasty. J Am Coll Cardiol. 1995;26:66-72.
15. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomized trials. Lancet. 2003;361:13-20.
16. Grines CL. Should thrombolysis or primary angioplasty be the treatment of choice for acute myocardial infarction? Primary angioplasty*the strategy of choice. N Engl J Med. 1996;335:1313-1317